Components of tumor stroma-immune microenvironment and their interactions in intrahepatic cholangiocarcinoma
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 3
Abstract
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant liver tumor, and due to the absence of symptoms in its early stage and the lack of effective treatment measures, patients tend to have an extremely low 5-year survival rate. The tumor stroma-immune microenvironment (TSIME) is a complex ecosystem that changes dynamically during tumorigenesis and evolution and consists of a variety of cellular and non-cellular components, and it plays an important role in the development, proliferation, invasion, and progression of ICC and determines the heterogeneity and malignancy of ICC to a certain degree. This article reviews the cellular components (such as T cells, B cells, natural killer cells, dendritic cells, neutrophils, macrophages, myeloid-derived suppressor cells) and non-cellular components (such as chemokines and cytokines) within the ICC TSIME, as well as the complex mechanisms of interaction between these components, and it also reviews the spatial interactions between immune cells and tumor cells, in order to provide potential research directions for ICC immunotherapy and new ideas for the effective and precise treatment of ICC in the future.
Authors and Affiliations
Qiulu ZHANG, Zhuo LI, Congrong LIU, Limei GUO
Effect of amino acid metabolic reprogramming on immune microenvironment of hepatocellular carcinoma
Tumor immune microenvironment is a local external tumor environment composed of tumor immune cells and the cytokines secreted by these cells, and it plays a regulatory role in the development and progression of tumors....
Study on the protective efect and mechanism of paeoniflorin on palmitic acid-induced HepG2 cells
[Objective] To investigate the role and mechanism of action of paeoniflorin (PF) in protecting HepG2 cells induced by palmitic acid (PA). [Methods] HepG2 cells were stimulated with PA at a concentration of 250 μmol/L...
Impact of anticentromere antibody on the clinical features and prognosis of patients with primary biliary cholangitis
[Objective] To investigate the impact of anticentromere antibody (ACA) on the clinical features and prognosis of patients with primary biliary cholangitis (PBC) by comparing clinical classification, ursodeoxycholic...
An excerpt of EASL clinical practice guidelines on the management of hepatocellular carcinoma(2024 edition)
Liver cancer is the third leading cause of cancer-related deaths worldwide, among which hepatocellular carcinoma (HCC) accounts for approximately 90% in primary liver cancer. The advances in diagnostic and treatment t...
Public health management strategies: A pathway to eliminating viral hepatitis threats
This article reviews the results of the 2020 national epidemiological survey of chronic viral hepatitis and its public health significance and discusses the differences in standard treatment and management rates and publ...